Last Price$302.80.6%
Market Cap$17.3B
LTM Return on Capital Employed (ROCE)
17.1%
5Y avg
18.6%
Medical - Healthcare Plans industry
median
4.4%
Stock quality & Intrinsic value
6/10
0.4% undervalued
Molina Healthcare, Inc. Return on Capital Employed (ROCE)
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Capital Employed (ROCE) | 8.3% | 10.9% | 10.0% | 9.4% | 5.9% | 8.3% | 3.6% | 2.4% | 7.1% | 6.0% | 8.2% | 3.9% | (15.8%) | 28.8% | 25.2% | 19.5% | 16.5% | 17.0% | 19.7% | 17.9% |
Overvalued or undervalued?
Check the intrinsic value for MOH
and see if it's the right time to invest.
Molina Healthcare, Inc. (MOH) Return on Capital Employed (ROCE) comparison analysis
General
LTM Return on Capital Employed (ROCE)
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Molina Healthcare, Inc.MOH
17.1%
19.3%
9.2%
2.9%
Median Peer Set
4.4%
7.2%
(11.9%)
1.1%
Elevance Health Inc.ELV
53.9%
3.2%
(0.0%)
3.4%
Oscar Health, Inc.OSCR
24.1%
56.5%
N/A
0.3%
UnitedHealth Group IncorporatedUNH
15.0%
8.9%
(35.7%)
3.6%
Humana Inc.HUM
6.9%
10.7%
(50.1%)
1.0%
Centene CorporationCNC
4.6%
5.9%
27.4%
2.0%
CVS Health CorporationCVS
4.1%
4.2%
(43.6%)
1.2%
Cigna CorporationCI
3.8%
8.4%
(18.9%)
2.6%
Clover Health Investments, Corp.CLOV
0.1%
(41.5%)
(31.3%)
(10.5%)
Alignment Healthcare, Inc.ALHC
(26.6%)
27.2%
(4.8%)
(8.1%)
Bright Health Group, Inc.BHG
(2,118.0%)
(51.9%)
86.2%
(103.4%)
MOH key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,650.1 40.4% | 2,005.0 21.5% | 2,492.5 24.3% | 3,112.4 24.9% | 3,669.4 17.9% | 4,086.0 11.4% | 4,769.9 16.7% | 6,028.8 26.4% | 6,588.9 9.3% | 9,666.6 46.7% | 14,072.0 45.6% | 17,711.0 25.9% | 19,883.0 12.3% | 18,890.0 (5.0%) | 16,829.0 (10.9%) | 19,423.0 15.4% | 27,771.0 43.0% | 31,974.0 15.1% | 34,072.0 6.6% | 40,650.0 19.3% |
| Cost of Goods Sold (COGS) | 1,424.9 | 1,678.7 | 2,080.1 | 2,621.3 | 3,176.2 | 3,449.5 | 4,004.0 | 5,397.0 | 5,713.6 | 8,616.1 | 12,434.0 | 15,941.0 | 18,003.0 | 16,266.0 | 14,394.0 | 16,746.0 | 24,491.0 | 28,048.0 | 29,738.0 | 0.0 |
% margin | 225.2 13.6% | 326.3 16.3% | 412.4 16.5% | 491.1 15.8% | 493.1 13.4% | 636.5 15.6% | 766.0 16.1% | 631.8 10.5% | 875.3 13.3% | 1,050.5 10.9% | 1,638.0 11.6% | 1,770.0 10.0% | 1,880.0 9.5% | 2,624.0 13.9% | 2,435.0 14.5% | 2,677.0 13.8% | 3,280.0 11.8% | 3,926.0 12.3% | 4,334.0 12.7% | 40,650.0 100.0% |
| Operating Expenses | 179.4 | 250.5 | 314.0 | 378.4 | 437.3 | 531.5 | 621.2 | 596.3 | 738.7 | 857.6 | 1,251.0 | 1,532.0 | 1,731.0 | 1,432.0 | 1,385.0 | 1,599.0 | 2,260.0 | 2,545.0 | 2,761.0 | 38,943.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 163.3 | 229.1 | 285.3 | 344.8 | 399.1 | 346.0 | 415.9 | 532.6 | 666.0 | 764.7 | 1,147.0 | 1,393.0 | 1,594.0 | 1,333.0 | 1,296.0 | 1,480.0 | 2,068.0 | 2,311.0 | 2,462.0 | 2,743.0 |
% margin | 45.8 2.8% | 75.8 3.8% | 98.3 3.9% | 112.6 3.6% | 57.4 1.6% | 105.0 2.6% | 80.2 1.7% | 35.5 0.6% | 136.6 2.1% | 192.9 2.0% | 387.0 2.8% | 238.0 1.3% | (555.0) (2.8%) | 1,131.0 6.0% | 1,044.0 6.2% | 1,078.0 5.6% | 1,020.0 3.7% | 1,173.0 3.7% | 1,573.0 4.6% | 1,707.0 4.2% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 87.0 | 102.0 | 120.0 | 110.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 4.6 | 8.7 | 13.8 | 15.5 | 15.5 | 16.8 | 52.1 | 56.8 | 67.0 | 101.0 | 118.0 | 115.0 | 87.0 | 102.0 | 120.0 | 110.0 | 109.0 | 118.0 |
| Pre-tax Income | 43.9 | 73.5 | 93.7 | 103.9 | 43.6 | 89.5 | 64.7 | 19.1 | 81.1 | 135.3 | 322.0 | 137.0 | (612.0) | 999.0 | 972.0 | 961.0 | 875.0 | 1,063.0 | 1,464.0 | 1,589.0 |
% effective tax rate | 16.3 37.1% | 27.7 37.8% | 35.4 37.7% | 41.5 39.9% | 12.7 29.2% | 34.5 38.6% | 43.8 67.8% | 9.3 48.6% | 36.3 44.8% | 72.7 53.8% | 179.0 55.6% | 129.0 94.2% | (100.0) 16.3% | 292.0 29.2% | 235.0 24.2% | 288.0 30.0% | 216.0 24.7% | 271.0 25.5% | 373.0 25.5% | 410.0 25.8% |
% margin | 27.6 1.7% | 45.7 2.3% | 58.3 2.3% | 62.4 2.0% | 30.9 0.8% | 55.0 1.3% | 20.8 0.4% | 9.8 0.2% | 52.9 0.8% | 62.2 0.6% | 143.0 1.0% | 8.0 0.0% | (512.0) (2.6%) | 707.0 3.7% | 737.0 4.4% | 673.0 3.5% | 659.0 2.4% | 792.0 2.5% | 1,091.0 3.2% | 1,179.0 2.9% |
| EPS | 0.67 | 1.09 | 1.37 | 1.50 | 0.79 | 1.34 | 0.45 | 0.21 | 1.16 | 1.33 | 2.75 | 0.93 | (9.14) | 10.61 | 11.85 | 11.41 | 11.40 | 13.70 | 18.71 | 20.43 |
| Diluted EPS | 0.65 | 1.08 | 1.37 | 1.50 | 0.79 | 1.32 | 0.45 | 0.21 | 1.13 | 1.29 | 2.58 | 0.92 | (9.14) | 10.55 | 11.48 | 11.24 | 11.25 | 13.54 | 18.78 | 20.43 |
% margin | 60.9 3.7% | 97.3 4.9% | 126.3 5.1% | 146.3 4.7% | 94.0 2.6% | 165.8 4.1% | 210.2 4.4% | 118.3 2.0% | 214.1 3.2% | 332.7 3.4% | 514.0 3.7% | 488.0 2.8% | (316.0) (1.6%) | 1,241.0 6.6% | 1,148.0 6.8% | 1,151.0 5.9% | 1,126.0 4.1% | 1,349.0 4.2% | 1,744.0 5.1% | 1,893.0 4.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Molina Healthcare, Inc.'s Return on Capital Employed (ROCE)?
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 17.1%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Return on Capital Employed (ROCE) for Molina Healthcare, Inc. have been 17.7% over the past three years, and 19.6% over the past five years.
2) Is Molina Healthcare, Inc.'s Return on Capital Employed (ROCE) Good?
As of today, Molina Healthcare, Inc.'s Return on Capital Employed (ROCE) is 17.1%, which is higher than industry median of 4.4%. It indicates that Molina Healthcare, Inc.'s Return on Capital Employed (ROCE) is Good.